Choice of surgical method for treatment of ameloblastoma of jaws depending on the histological subtype of the tumor

2023

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.51582/interconf.19-20.02.2023.036
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

In maxillofacial surgery, the generally accepted method of treating ameloblastoma (malignancy 1.5-4%) is a radical removal of the formation with a resection of the lower jaw within healthy tissues. However, given the relatively favorable clinical course of ameloblastoma of the first and second groups of AB, we believe that radicalism should be reasonably sufficient in order not to disable the patient.